Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.

about

Organic Ion Transporters and Statin Drug Interactions.SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case-control study.

P2860

Q47361769-8C6D773A-5860-446E-80D5-73780DEB25EB Q53099880-82E8D997-C78B-495A-AEB5-BA32F25D00AD

P2860

Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.

Item

http://www.wikidata.org/entity/Q40594690

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Statin-associated muscle sympt ...... familial hypercholesterolemia.

@en

type

Item

label

Statin-associated muscle sympt ...... familial hypercholesterolemia.

@en

prefLabel

Statin-associated muscle sympt ...... familial hypercholesterolemia.

@en

P1476

Statin-associated muscle sympt ...... familial hypercholesterolemia.

@en

P2093

Beverley Adams-Huet

http://www.w3.org/2001/XMLSchema#string

Htet Khine

http://www.w3.org/2001/XMLSchema#string

Zahid Ahmad

http://www.w3.org/2001/XMLSchema#string

P2860

Monogenic hypercholesterolemia: new insights in pathogenesis and treatment

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review

SLCO1B1 variants and statin-induced myopathy--a genomewide study

Treatment strategies in patients with statin intolerance: the Cleveland Clinic experience.

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.

Discontinuation of statins in routine care settings: a cohort study.

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

The SLCO1B1*5 genetic variant is associated with statin-induced side effects.

Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AHJ.2016.05.015

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

179

http://www.w3.org/2001/XMLSchema#string

P50

Wei Cheng Yuet

P577

2016-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27595674

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

P932

5014387

http://www.w3.org/2001/XMLSchema#string

Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.

about

P2860

P2860

Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932